Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.
Albert Labs Scientific and Clinical Advisory Boards will support the company’s efforts to develop its proprietary psychedelics-based medicine and conduct accelerated studies on UK patients suffering from cancer-related anxiety. JUNE…
Albert Labs going public soon. JUNE 03 , 2021 - VANCOUVER, BRITISH COLUMBIA, ME Resource Corp (“MEC” or the “Company”)(CNSX: MEC | OTC: MEEXF) announced today that the Company has submitted…
Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies May 25TH , 2021 - VANCOUVER, BRITISH COLUMBIA, Albert Labs,…
© 2023 Albert Labs. All Rights Reserved
We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.
If you would like support or more information around making an investment, please contact [email protected]
Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.
By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.
